Durect

Read more
James E. Brown's photo - President & CEO of Durect

President & CEO

James E. Brown

CEO Approval Rating

87/100

Founded:

1998

Status:

PublicIndependent CompanyNASDAQDRRX

DURECT TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Durect's company profile
James E. Brown's photo - President & CEO of Durect

James E. Brown

President & CEO

87/100
88
$84M
$8.5M
View Profile
1
Durect's Competitor - Recro Pharma logo
Gerri Henwood's photo - President & CEO of Recro Pharma

Gerri Henwood

President & CEO

94/100
255
$160.2M
$64M
View Profile
2
Durect's Competitor - Semnur Pharmaceuticals logo
Jaisim Shah's photo - President & CEO of Semnur Pharmaceuticals

Jaisim Shah

President & CEO

69/100
28
$6M
$2.5M
View Profile
3
Durect's Competitor - Innocoll logo
Louis Pascarella's photo - President & CEO of Innocoll

Louis Pascarella

President & CEO

83/100
105
$88.5M
$4.4M
View Profile
4
Durect's Competitor - Purdue Pharma L.P. logo
Craig Landau's photo - President & CEO of Purdue Pharma L.P.

Craig Landau

President & CEO

66/100
5,000
- -
$3B
View Profile
5
Durect's Competitor - Endo logo
Blaise Coleman's photo - President & CEO of Endo

Blaise Coleman

President & CEO

88/100
3,397
$2.8B
$2.8B
View Profile
6
Durect's Competitor - Intarcia logo
Kurt Graves's photo - Chairman & CEO of Intarcia

Kurt Graves

Chairman & CEO

81/100
310
$1.5B
$47.8M
View Profile
7
Durect's Competitor - Zosano Pharma logo
Steven Lo's photo - President & CEO of Zosano Pharma

Steven Lo

President & CEO

83/100
53
$215.5M
$ < 1M
View Profile
8
Durect's Competitor - Heron logo
Barry Quart's photo - Chairman & CEO of Heron

Barry Quart

Chairman & CEO

92/100
198
$174M
$83M
View Profile
9
Durect's Competitor - Iroko logo
Louis J. Vollmer's photo - President & CEO of Iroko

Louis J. Vollmer

President & CEO

85/100
50
$215M
$50M
View Profile
10
Durect's Competitor - Zogenix logo
Stephen J. Farr's photo - President & CEO of Zogenix

Stephen J. Farr

President & CEO

81/100
90
$494.3M
$43.8M
View Profile
11
Durect's Competitor - Centrexion logo
Jeffrey B. Kindler's photo - CEO of Centrexion

Jeffrey B. Kindler

CEO

90/100
50
$174M
$56M
View Profile

Missing a competitor? Contribute!

Recro Pharma is perceived as one of Durect's biggest rivals. Recro Pharma was founded in 2007, and is headquartered in Malvern, Pennsylvania. Like Durect, Recro Pharma also competes in the Pharmaceuticals space. Recro Pharma generates $53M more revenue vs. Durect.

Semnur Pharmaceuticals is a top competitor of Durect. Semnur Pharmaceuticals is a Private company that was founded in 2013 in Mountain View, California. Like Durect, Semnur Pharmaceuticals also works within the Pharmaceuticals sector. Compared to Durect, Semnur Pharmaceuticals has 60 fewer employees.

Innocoll is Durect's #3 rival. Innocoll is headquartered in Newtown Square, Pennsylvania, and was founded in 1985. Innocoll operates in the Pharmaceuticals industry. Innocoll generates 51% the revenue of Durect.

Durect Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$8.5M

Durect's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 515.6M. Over the last four quarters, Durect's revenue has decreased by 14.2%. Specifically, in Q2 2021's revenue was $2.3M; in Q1 2021, it was $2.2M; in Q4 2020, it was $1.3M; in Q3 2020, Durect's revenue was $2.7M.

Durect Acquisitions

No recent acquisitions found related to Durect

Durect Funding History

Since Durect was founded in 1998, it has participated in 1 round of funding. In total Durect has raised $84.0M. Durect's funding round was on Sep 2000 for a total of $84.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Sep 2000
$84M
-

Since Durect was founded in 1998, it has participated in 1 round of funding. In total Durect has raised $84.0M. Durect's funding round was on Sep 2000 for a total of $84.0M

Durect Investments

No recent investments found related to Durect

Durect News

June 16, 2021MarketScreener

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Durect Corporation (Form 8-K)

(marketscreener.com) CERTIFICATE OF AMENDMENT OF THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO... See more »
April 27, 2021BioSpace

DURECT Corporation to Announce First Quarter 2021 Financial Results and Provide Business Update on May 4

DURECT Corporation (Nasdaq: DRRX) today announced that it will report its first quarter 2021 financia... See more »
March 5, 2021MarketScreener

Announces Fourth Quarter and Full Year 2020 Financial Results and Update of Programs

(marketscreener.com) CUPERTINO, Calif., March 4, 2021 /PRNewswire/ -- DURECT Corporation today announ... See more »
March 3, 2021Markets Insider

DURECT Corporation to Participate in Three Investor Conferences in March 2021

CUPERTINO, Calif., March 3, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced th... See more »
February 4, 2021MarketScreener

Announces Pricing of $42.5 Million Public Offering of Common Stock

(marketscreener.com) CUPERTINO, Calif., Feb. 4, 2021 /PRNewswire/ -- DURECT Corporation , a biopharma... See more »
January 25, 2021MarketScreener

Announces First Patient Dosed in Phase 2b AHFIRM Study of DUR-928 in Severe Alcohol-Associated Hepatitis

(marketscreener.com) CUPERTINO, Calif., Jan. 25, 2021 /PRNewswire/ -- DURECT Corporation today announ... See more »
January 5, 2021MarketScreener

Appoints Two New Board Members

(marketscreener.com) CUPERTINO, Calif., Jan. 5, 2021 /PRNewswire/ -- DURECT Corporation today announc... See more »

Durect Press Releases

January 3, 2020centralcharts

DURECT Corporation - DRRX Stock Chart Technical Analysis for 01-03-2020

News videos - DURECT Corporation - DRRX Stock Chart Technical Analysis for 01-03-2020 - Published on ... See more »
June 25, 2019PR Newswire

DURECT Receives Approval from Nasdaq for Transfer of Listing to Nasdaq Capital Market

CUPERTINO, Calif., June 25, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced th... See more »
May 16, 2019PR Newswire

DURECT to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019

CUPERTINO, Calif., May 16, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today tha... See more »
May 8, 2019CentralCharts

DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial

CUPERTINO, Calif., May 7, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced prel... See more »
May 7, 2019centralcharts

DURECT Corporation Announces First Quarter 2019 Financial Results and Update of Programs

CUPERTINO, Calif., May 7, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced fina... See more »
May 7, 2019StreetInsider

DURECT Corporation Announces First Quarter 2019 Financial Results and Update of Programs

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended March ... See more »
May 7, 2019StreetInsider

DURECT Corporation Announces Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial

DURECT Corporation (Nasdaq: DRRX) today announced preliminary data from the ongoing DUR-928 alcoholic... See more »

Social Media

Durect Headquarters

10260 Bubb Road

Cupertino, California95014

408-777-1417

Driving Directions »

Trending Companies

Durect Summary

ABOUT

Overview

DURECT focused on the development of pharmaceutical products based on its drug delivery technology platforms.  Durect was founded in 1998. Durect's headquarters is located in Cupertino, California, USA 95014. Durect's President & CEO, James E. Brown,...

CEO

Durect's President & CEO, James E. Brown, currently has an approval rating of 87%. Durect's primary competitors are Recro Pharma, Semnur Pharmaceuticals & Innocoll.

Website

durect.com

Frequently Asked Questions about Durect

  1. When was Durect founded?

    Durect was founded in 1998
  2. Who is Durect's CEO?

    Durect's CEO is James E. Brown
  3. How much revenue does Durect generate?

    Durect generates $8.5M in revenue
  4. How much funding does Durect have?

    Durect has historically raised $84M in funding
  1. Where is Durect's headquarters?

    Durect's headquarters is in Cupertino California, USA
  2. How many employees does Durect have?

    Durect has 88 employees
  3. What sector does Durect operate in?

    Durect is in Pharmaceuticals
  4. Who are Durect's competitors?

    Durect's top competitors are Recro Pharma, Semnur Pharmaceuticals, Innocoll